- Previous Close
44.00 - Open
43.90 - Bid 41.00 x --
- Ask 41.65 x --
- Day's Range
41.00 - 45.65 - 52 Week Range
33.85 - 51.10 - Volume
357,721 - Avg. Volume
175,602 - Market Cap (intraday)
2.766B - Beta (5Y Monthly) --
- PE Ratio (TTM)
20.24 - EPS (TTM)
2.06 - Earnings Date --
- Forward Dividend & Yield 1.21 (3.26%)
- Ex-Dividend Date Jul 17, 2023
- 1y Target Est
--
Vetnostrum Animal Health Co., Ltd. engages in the production and sale of animal health products in Taiwan and the Asia Pacific. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company is based in Taichung, Taiwan.
www.vetnostrum.comRecent News: 6936.TWO
View MorePerformance Overview: 6936.TWO
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6936.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6936.TWO
View MoreValuation Measures
Market Cap
2.93B
Enterprise Value
2.85B
Trailing P/E
21.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.27
Price/Book (mrq)
2.59
Enterprise Value/Revenue
2.20
Enterprise Value/EBITDA
11.53
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
2.06
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--